title: Raynaud's phenomenon and celiac disease.
authors.forename: M
authors.initials: M
authors.lastname: Gabrielli
authors.forename: M
authors.initials: M
authors.lastname: Candelli
authors.forename: L
authors.initials: L
authors.lastname: Santarelli
authors.forename: E C
authors.initials: EC
authors.lastname: Nista
authors.forename: A
authors.initials: A
authors.lastname: Santoliquido
authors.forename: G
authors.initials: G
authors.lastname: Gasbarrini
authors.forename: P
authors.initials: P
authors.lastname: Pola
authors.forename: A
authors.initials: A
authors.lastname: Gasbarrini
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000276:immunology*; D016022:Case-Control Studies; D002446:Celiac Disease / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D015331:Cohort Studies; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D015994:Incidence; D008297:Male; D011928:Raynaud Disease / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D018570:Risk Assessment
chemical_list: D000974:Antibodies, Antinuclear; D007070:Immunoglobulin A